Checkout
Please register your details and proceed to checkout.
Seizures Drug Pipeline Analysis 2024: By Clinical Trial Phase: Late-Stage Products (Phase III and Phase IV), Mid-Stage Products (Phase II), Early-Stage Products (Phase I), Preclinical and Discovery Stage Products; By Therapy Type: Monotherapy, Combination Therapy; By Drug Class: Sodium Channel Blockers, Calcium Channel Blockers, Gamma-Aminobutyric Acid (GABA), Enhancers Glutamate Receptor Antagonists; Route of Administration; Drug Profile; Key Players
Single User License
$ 2499.00
Total Price: $ 2499.00
We use cookies, just to track visits to our website, we store no personal details. Privacy PolicyX
Reports
Press Release
Blogs
Price Forecast